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We describe here a new organ culture system for the evaluation of viral tropism to colon carcinomas and normal colon tissues. Organ cultures
of mouse and human colon retained viability for several days and thus facilitated studies of viral tropism. Two adenoviral vectors (AD) were
compared in the study: AD5, that utilizes the CAR receptor, demonstrated poor infectivity to both normal and carcinoma tissues, while a capsid-
modified-AD, recognizing haparan-sulfate receptor, demonstrated efficient infectivity of both tissues. Immunohistochemistry analysis
demonstrated different viral tropism; while AD5 infected only the colon epithelia, the capsid-modified-adeno infected both the epithelia and
mesothelial layers. To investigate other determinants in the tissue that influence viral tropism, human cancer tissues were pretreated with
collagenase and infected with the AD viruses. Increased infectivity and altered tropism were noted in the treated tumor tissue. Taken together, this
ex vivo system indicated that receptor utilization and extracellular-matrix components influence AD viral tropism in solid tissues.
© 2006 Elsevier Inc. All rights reserved.Keywords: Organ cultures; Colon carcinoma; Modified adenovirus; TropismIntroduction
Colon carcinoma is the second most common cause of death
from cancer in the western world and multiple approaches,
including gene therapy, have been pursued as experimental
treatments (McKenzie et al., 2005). In order to evaluate gene
therapy vectors for the transfer of a therapeutic gene, selectively
to the tumor tissue, several experimental models have been
established, primarily, tumor cell lines in culture and animal
models with implanted tumor cells (Kanerva et al., 2002;
O'Malley et al., 1996). However, these approaches are imperfect
in gene therapy studies for the following reasons: Firstly, tumor
cells in culture do not recapitulate the three-dimensional structure⁎ Corresponding author. Fax: +972 2 6757402.
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doi:10.1016/j.virol.2006.07.048of the tissue that includes several cell types and a variety of
extracellular matrix components that may affect accessibility of
the gene transfer vector. Secondly, culturing of the parental
normal cell, as a control for the tumor cells, is often impossible,
especially for epithelial tissues. Animal models of cancer are
complex, as the immune system and circulating cytokines
effectively influence both tumor growth and tropism of the gene
transfer vector. Solid tissues maintained ex vivo as organ cultures
provide an alternative experimental system to overcome these
shortcomings (Booth et al., 2004; Brill-Almon et al., 2005;
Hasson et al., 2005; Kirby et al., 2004; McBride et al., 2000). We
have previously demonstrated that various normal tissues of
human and animal origins may be maintained ex vivo as organ
cultures and applied for the study of viral vector infection and
spread within solid tissues (Brill-Almon et al., 2005; Hasson et
al., 2005). Organ cultures derived from normal liver tissue, and
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applied for the study of gene transfer by viral vectors (Kirby et
al., 2004; Rots et al., 2005; Stoff-Khalili et al., 2005, 2006). Yet,
no comparison of viral vector tropism to any tumor tissue and the
equivalent normal tissue has been done to date.
Application of gene therapy approaches for the treatment of
colon carcinoma is especially attractive as the primary tumor is
directly accessible to local administration of the vector and thus
systemic vector spread is minimal. In this study, we describe the
development of a new organ culture system to evaluate the
utility of adenoviral vectors as gene delivery vehicles in the
context of colon cancer compared to the normal colon.
Adenoviral vectors (AD) are of great interest in gene therapy
and cancer targeting due to their relative ease of preparation to
high titers and the capacity to effectively infect a variety of cell
types (Hemminki and Alvarez, 2002; Hemminki et al., 2001).
Infection by adenovirus type-5 (AD5) is initially mediated by
attachment through its capsid fiber protein to the cell surface
receptor, coxsackievirus–adenovirus receptor (CAR). Subse-
quently, interactions of the AD penton base protein with
αv-integrin trigger endocytosis of the virus (Meier and Greber,
2004). However, some normal and cancerous cells are poorly
infected by AD5 as they express low levels of CAR and often
only in the basolateral membrane of the epithelial target cells
(Bruning and Runnebaum, 2003; Cohen et al., 2001; Hemminki
et al., 2003; Kanerva et al., 2002; Li et al., 1999; Pickles et al.,
2000; Seidman et al., 2001). To overcome these restrictions, Wu
et al. (2002) have genetically modified the AD5 fiber protein to
include two peptide motifs; (I) an RGD sequence to improve the
interaction with integrin receptors for the internalization of the
virus (AD5RGD). (II) A stretch of seven lysine residues
(AD5RGDPK7) to facilitate virus binding through cell surfaceFig. 1. Viability of colon tissues in organ culture. Normal and malignant murine colo
and incubated for the indicated times prior to viability analysis. (A, B) Histological sec
24 h of incubation and stained with H&E. (C, D) MTT viability assay was carried out
absorbance (540 nm) of the formazan product created indicates cell viability. Higheheparan sulfate molecules rather then the CAR. Indeed,
improved infectivity towards several cell lines and primary
tissues was noted with the modified viruses, especially with the
AD5RGDPK7 (Bilbao et al., 2002; Contreras et al., 2003;
Dehari et al., 2003; Hemminki et al., 2001; Kanerva et al., 2002;
Reynolds et al., 1999; Stoff-Khalili et al., 2005; Wickham et al.,
1996; Wu et al., 2004).
In the present work, we applied a new organ culture system
to study the tropism of capsid-modified AD to normal and
cancerous colon of human and mouse origin. The type of the
transduced cells and the level of tissue infection were compared
between normal and cancerous colon tissues. Furthermore,
results obtained with the organ culture methodology were
validated using an in vivo mouse model of colon carcinoma.
Results
Establishment of organ cultures from normal and malignant
colon tissues
Organ cultures were prepared from fresh tissues of mouse
and human origin as described in Materials and methods.
Mouse colon carcinoma cells (CT26) were injected directly to
the rectal sub-mucosa of Balb/C mouse colon in order to create
an orthotopic model of the disease (Kashtan et al., 1992).
Human colon tissues were processed within 2 h of the surgery
(human tissues were obtained under approval of the hospital
IRB committee). The mitochondrial dehydrogenase enzyme
assay (MTT) was adopted for the evaluation of colon tissues
viability during the period of the experiments ex vivo.
The results shown in Figs. 1C and D demonstrate stable
dehydrogenase enzyme specific activity in both the carcinoman tissues were prepared for organ culture as described in Materials and methods
tions (5 μm) were prepared from organ cultures of normal and tumor tissues after
on equal amounts of protein extracts, as described in Materials and methods. The
r absorbance correlates with higher viability. Data reflect means (+) SD, n=6.
Table 1
Titration of capsid-modified viruses on different cells of human and mouse
origin
CELLS AD5
(IU/ml)
AD5RGDPK7
(IU/ml)
Infection ratio
AD5RGDPK7/
AD5
293 (human kidney) 2×108 2×108 1
LS174T (human colon goblet cell) 1.4×105 6.3×105 4.6
NIH 3T3 (mouse fibroblast) 4×108 3.7×108 0.93
CT26 (mouse colon carcinoma) 5.2×103 2.9×104 5.6
Cell lines (human 293T, LS174T and mouse 3T3, CT26), were seeded
(40,000 cells/well in 96 wells plate) and after 12 h infected with serially
logarithmic diluted of virus preparations. 50 μl of infection medium without
FCS was added to every well. Two hours later, 50 μl of complement FCS
medium was added. Infections were performed in 10 replicates. At 48 h after
infection, number of GFP positive well was determined using fluorescent
microscope and titer calculated by end point titration.
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during the first 24 h following surgical removal. All subsequent
experiments employed, therefore, this period of ex vivo culture.
Moreover, histology analysis of the colon tissue after 24 h inFig. 2. Capsid-modified adenovirus efficiently infects normal and orthotopic mouse
mice were prepared for organ culture as described in Materials and methods. Same-si
either AD5 or AD5RGDPK7 (2×106 infectious units/well) as described in Materials
expression under a fluorescent microscope and photographed at ×100 magnification.
reporter gene expression. Specific activity of the luciferase enzyme was normalized
Results are representative of three independent experiments. The spots of brighter
Asterisks indicate that organ culture infection with the AD5RGDPK7 was significant
(For interpretation of the references to colour in this figure legend, the reader is refeculture shows normal appearance of the epithelial cell layer, as
well as the other constituents of a normal mouse colon (Fig.
1A). The tumor tissue exhibited CT26 carcinoma cells that grow
as an orthotopic tumor within the normal colon of mice (Fig.
1B). Thus, the new organ culture of colon tissues facilitated the
study of colon cancer versus normal colon in the context of gene
transfer.
Titration of capsid-modified viruses on different cells of human
and mouse origin
Since the organ cultures were derived from either mouse or
human origin, for a direct comparison of infectivity to the
normal and tumor tissues, we chose to titrate the different
adenovirus preparations on both human and mouse cell lines.
The results presented in Table 1 indicated that the two viruses
(AD5 and AD5RGDPK7) gave similar titers on human kidney
293 cells and on mouse NIH3T3 fibroblasts. However, the same
viral preparations displayed much lower infectivity on two cell
lines, derived of human colon goblet cells (LS174T) and of
mouse colon carcinoma cells (CT26). The capsid-modifiedcolon carcinoma tissues ex vivo. Orthotopic colon carcinoma tissues of Balb/C
ze tumor and colon tissue slices were prepared (n=5) and infected for 24 h with
and methods. (A) Organ cultures were taken after 24 h for examination of GFP
(B) Twenty-four hours post infection, organ cultures were analyzed for luciferase
per protein content of the extracts. Data reflect mean (±) SD, n=6 replicates.
green (as shown by arrows) seen in II, III, V and VI indicates viral infection.
ly enhanced when compared to infection with AD5, at the same doses, *P<0.05.
rred to the web version of this article.)
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infectivity as compared to AD5 on the two colon cell lines. In
all subsequent experiments, a similar titer of the viruses, as
determined on 293T and 3T3 cells, was used for infection of
both the normal and tumor tissues.
The capsid-modified adenovirus efficiently infects both normal
and malignant mouse colon tissues
Following infection with the two AD vectors, the native
colon tissues were observed for expression of the reporter GFP
under a fluorescent microscope (Fig. 2A, I–VI). Modification
of the capsid (AD5RGDPK7) significantly enhances infection
of both normal and malignant mouse colon tissues as
compared with AD5. For quantitative analysis of the infection,
the tissues were extracted and expression level of a second
reporter gene product, the luciferase enzyme, was determined.
The results presented in Fig. 2B support the in situ observation
of reporter GFP expression in the colon tissues. Capsid-
modified AD5RGDPK7 shows a much higher infection of
both the normal (x5.2) and cancerous tissues (x34), as
compared to AD5. It is interesting to note that both AD5
and the capsid-modified virus AD5RGD (utilizing the integrinFig. 3. Capsid-modified adenovirus primarily infects mucosa and mesothelial cells in
for 24 h as described in Fig. 2. Immunohistochemistry analysis was carried out with a
and methods. The higher degree of brown staining (as shown by the arrows) indicates
(Mock) and infected normal colon sections at ×100 magnification. ×400 magnifica
×200 magnification. (G–I) Photomicrographs of uninfected and infected colon carci
propria, Meso.=mesothelial layer. (For interpretation of the references to colour inreceptor) demonstrated higher extent of infection of normal
colon, as compared to the carcinoma tissue (x6 and x4.6,
respectively), while the AD5RGDPK7 infected equally well
the two tissues.
The observation that tissue infection with capsid-modified
viruses is higher than that of the parental AD5, could be a result
of altered viral tropism, due to utilization of a different receptor
expressed by other cell type, or due to a more efficient infection
of the same type of cells within the tissue. To differentiate
between these possibilities, immunohistochemical analysis of
tissues infected by the different viruses was carried out.
Immunostaining of normal mouse colon infected with AD5,
using antibodies to the reporter protein GFP, indicated sparse
infection of epithelial cells within the gut mucosa layer (Figs.
3B and E). Infection with capsid-modified virus AD5RGDPK7
resulted in intense infection of the same epithelial layer and in
addition infection of cells in the mesothelial layer of the colon
(Figs. 3C and F, Brown stain). The tumor tissue exhibited no
cell regularity, as expected, and infection with capsid-modified
AD5RGDPK7 virus resulted in extensive infection of the tumor
cells, as compared with low infection by AD5 (Figs. 3H and I ).
Taken together, the results presented in Figs. 2 and 3 suggest
that receptor utilization in a given tissue determines adenovirusthe normal colon. Organ cultures were prepared from mice tissues and infected
ntibodies to GFP (A–F) and luciferase antigens (G–I), as described in Materials
a more efficient infection of the tissues. (A–C) Photomicrographs of uninfected
tion shows staining of the mesothelial layer (C). (D–F) Normal colon sections,
noma sections at ×400 magnification. Muc.=mucosal layer, Musc.=Muscularis
this figure legend, the reader is referred to the web version of this article.)
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constituting a tissue.
Capsid modification of adenovirus enhances gene delivery
in vivo
To validate the ex vivo system of organ culture for viral
infection, tumors of CT26 cells were induced in mice and
subsequently injected intratumorally with equal amounts of the
two viruses. Extent of tumor infection in vivo was estimated,
using a CCCD camera (Arad et al., 2005; Honigman et al.,
2001), through expression of the reporter luciferase gene of the
viruses, after injection (i.p.) of the enzyme substrate, luciferin
(Figs. 4A and B). The results clearly indicate a much higher
infection, at the tumor site, by capsid-modified AD5RGDPK7
as compared with AD5. Next, the tumor tissues were removed
and luciferase enzyme activity was quantitatively determined in
protein extracts prepared from the tumors. Results presented in
Fig. 4C indicate a 25-fold higher infection of tumor tissues by
AD5RGDPK7, as compared with AD5.
Capsid-modified AD effectively infects normal and malignant
colon tissues of human origin
Since AD5 is a human virus, animal models may not reflect
the human situation. We therefore established organ cultures of
human colon tissues, obtained from the surgery room, and
compared infectivity of the capsid-modified viruses with that of
AD5. As tissues obtained from different patients vary withFig. 4. Capsid modification of adenovirus enhances gene transfer in vivo. Balb/C mice
later, as tumors developed, mice groups (n=4) were injected with (A) AD5 vector (2
units). Results are representative of the different groups. After 48 h, mice were anesthe
with luciferin (PromegaCorp.) in PBS (126mg/kgbodyweight).After the imagewas su
dark box, supplementedwith a controlled light to take pictures of the background image
group, using a plug-in module, is presented (Arad et al., 2005; Honigman et al., 200
described above (n=4 for each group). Tissue of each animal was lysed separately and
methods. Data presented in panel C reflect mean (+) SD of 4 animals. Asterisk ind
compared to infection with AD5, at the same virus dose, *P<0.05.respect to viability and the relative position of the tumor tissue
with respect to the adjacent normal tissue, we repeated infection
experiments with tissues from four patients. Representative
results of viral infection with tissues from two patients are
presented in Fig. 5. Using the GFP reporter, as a measure of
viral infection, it is clear that AD5RGDPK7 virus infects both
the carcinoma and the normal peritoneum tissue much more
effectively then AD5 (Fig. 5A). Furthermore, quantitative
analysis of the reporter luciferase enzyme specific activity in
crude extracts derived form infected tissues of two patients
shows a 17-fold higher infection by AD5RGDPK7 as compared
with AD5 (Fig. 5B). To investigate whether differences in
infectivity between the two viruses can be overcome by
increasing the viral multiplicities, tissues from patient#1 were
infected at two virus doses (Fig. 5B, patient#1). The results
indicate a multiplicity dependent infection by the viruses to both
the normal and carcinoma tissues. Since the number of cells in
an organ culture slice could be estimated, after measuring the
DNA content of the tissue (Materials and methods; Downs and
Wilfinger, 1983), we calculated the approximate multiplicities
of infection in the organ cultures. In all experiments presented in
this work, multiplicities of infection (MOI) were lower then one
virus per cell, assuming optimal accessibility of all cells within
the tissue to the infecting virus. Notwithstanding, relative
efficiencies of infection by the two viruses were maintained at
both multiplicities. Consistently, infection with the capsid-
modified AD5RGDPK7 was much higher then that of AD5, in
the human normal tissue (x7–x25) and in the colon carcinoma
(x8–x19).(n=12) were injected s.c. with 5×105 colon carcinoma cells (CT26). Two weeks
×106 infectious units) or (B) Adeno-modified AD5RGDPK7 (2×106 infectious
tized. Ten minutes before monitoring of light emission, animals were injected i.p.
perimposed in real timeover the gray-scalemouse image, animalswere placed in a
or exposed to the CCCD. The composite image of a representative animal of each
1; Iris et al., 2003). (C) Infected tumor tissues were harvested from the 12 mice
luciferase enzyme specific activity was determined as described in Materials and
icates that intratumor infection with AD5RGDPK7 was significantly enhanced
Fig. 5. Colon tissues of human origin are effectively infected by AD5RGDPK7. Tissues of human colon and colon carcinoma were obtained from the surgery room
(Approval # 20-01/08/03 by the IRB committee of the Hadassah hospital). Organ cultures were immediately prepared as described in Materials and methods and same-
size tumor and colon tissue slices were prepared (n=5) and infected by either AD5 or AD5RGDPK7 (4×104 and 5×105 IU (patient 1) and 1×106 IU (patient 2)).
(I–VI) After 24 h of infection, native tissues were observed for GFP expression under fluorescent binocular (1000× magnification). The spots of brighter green
indicate viral infection. (B) Infected organ culture tissues were extracted and tested for luciferase enzyme specific activity as described in Materials and methods.
Results of a representative experiment with tissues from two patients out of four are presented. Asterisks indicate that organ culture infection with AD5RGDPK7
was significantly enhanced compared to infection with AD5, at the same dose, *P<0.05. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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AD5RGDPK7
It was previously demonstrated, using a cultured cell line,
that capsid-modified AD5RGDPK7 utilizes heparin sulfate as a
receptor (Wu et al., 2002). We investigated here whether
infection of a colon tissue, containing various types of cells, is
also dependent on the haparan sulfate as a receptor. To this end,
mouse colon tissue was infected in the presence of soluble
heparin. The results presented in Fig. 6 show that heparin, at
high concentration, inhibits infection of the tissue by the
AD5RGDPK7 but not by AD5. It should be noted, however,that inhibition of AD5RGDPK7 virus by heparin was only
partial (52%), suggesting alternative receptors for the capsid-
modified virus in the colon tissue.
In summary, the results presented in Figs. 2, 5 and 6 clearly
indicate that receptor utilization affects both the tropism and
extent of infection of the virus in a three dimension solid tissue.
Partial degradation of collagen enhances gene delivery to
human colon carcinoma tissue
To investigate whether extracellular matrix components, that
are specific in each solid tissue, also influence viral infectivity,
Fig. 6. Heparin partially blocks colon tissue infection with AD5RGDPK7.
Organ cultures prepared from a normal mouse colon tissue were infected with
either AD5 or AD5RGDPK7 (2×106 IU ), in the presence of heparin at 5 μg/ml
or 100 μg/ml, for 2 h and the unbound virus and heparin were removed by
several washing with PBS. The tissues were further incubated for 22 h as
described in Materials and methods. The tissues were extracted for luciferase
enzyme assay as described in Materials and methods. Results are illustrated as
percent luciferase specific activity, relative to an identical infection in the
absence of heparin (taken as 100%). Data reflect means (±) SD, n=6. Asterisk
indicates that infection of organ cultures with AD5RGDPK7 in the presence of
heparin was significantly lower compared to an identical infection without
heparin, *P<0.05.
Fig. 7. Degradation of collagen matrix enhances gene delivery in solid tissues.
Human colon carcinoma organ cultures were either pretreated or not with
collagenase 2 (50 μg/ml, Worthington Biochemical Corp.) for 2 h at 37 °C. Next,
tissues were infected for 24 h with AD5 or AD5RGDPK7 (5×105IU) as
described in Materials and methods. Gene transfer 24 h post infection was
evaluated by (A) GFP expression, (B) luciferase specific activity as described in
Materials and methods. Asterisk indicates that organ culture infection with
AD5RGDPK7 after collagenase pretreatment was significantly enhanced when
compared to AD5RGDPK7 without collagenase treatment, *P<0.05.
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Collagenase 2 enzyme to digest collagen I, II, III, VII and X.
The results presented in Fig. 7 indicate that partial digestion of
extracellular collagen facilitated a more efficient tissue
infectivity by both the capsid-modified AD5RGDPK7 and
AD5. Relative extent of infection by the two viruses, however,
was maintained, regardless of the collagen content in the tissue
(x 2.4). Since many more cells appear to be infected within the
collagenase-treated tissue, it is possible that accessibility of cells
within a solid tissue to the infecting virus is limited due to the
collagen matrix.
Discussion
Despite early detection procedures and multimodality
therapy, colorectal cancer remains the number two cause of
cancer-related death in the United States (McKenzie et al.,
2005). Current therapy of colorectal cancer involves surgical
resection of the primary tumor, frequently combined with
chemo and radiotherapy. In order to reduce the tumor mass
and allow for less destructive surgery, patients with carcinoma
of the rectum usually undergo chemo-radio therapy prior to
surgery. As the gene transfer vector can be injected directly to
the rectal carcinoma tissue with relative ease, this tumor is an
attractive target for localized gene therapy that may enable to
eliminate or reduce exposure to radiation or to cytotoxic
drugs.
While much experience has been gained with adenovirus for
tumor therapy in animal models, there is little evidence
supporting significant clinical benefits with the common
adenoviral vector, i.e. group C viruses comprising serotypes 2
and 5. One of the factors accounting for tumor resistance toinfection with adenovirus appears to be low level expression of
the coxsackievirus–adenovirus receptor (CAR) in many
cancers, inclusive of colon carcinoma (Bruning and Runne-
baum, 2003; Cohen et al., 2001; Hemminki et al., 2003;
Kanerva et al., 2002; Li et al., 1999; Pickles et al., 2000;
Seidman et al., 2001). Yet another important issue in cancer
therapy is the selectivity of the treatment to the tumor tissue as
compared with toxicity to the equivalent normal tissue. Only
little is known of the selectivity of viral vectors to tumor versus
normal tissues. To address these problems within the context of
colon carcinoma, we employed a new system of organ culture
(normal colon and colon carcinoma) that recapitulates the target
organ for gene transfer (Brill-Almon et al., 2005; Hasson et al.,
2005).
In this study, we tested capsid-modified adenoviruses
(AD5RGD and AD5RGDPK7) for infectivity enhancement
and selectivity to colon carcinoma over the normal colon
tissue. These adenoviral vectors display an RGD ligand and a
ligand of seven lysine residues, thereby recognizing alpha-V
integrin and heparan sulfate receptors, respectively, and is
independent of the CAR receptor (Wu et al., 2002). The
capsid-modified AD5RGDPK7 virus has been previously used
to examine infection of other tumors, specifically, ovarian and
breast cancer models, but no comparison to the equivalent
normal tissue was carried out (Bauerschmitz et al., 2002;
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Rein et al., 2004; Stoff-Khalili et al., 2005). The cellular
tropism of these viruses has not been determined for any tissue.
We observed that while the RGD capsid-modified AD was only
moderately more infectious then AD5 (i.e. 2-fold), the capsid-
modified AD5RGDPK7 significantly enhanced gene transfer in
mouse and human colon tissues (19-fold and 34-fold, respec-
tively). Although the capsid-modified AD vector AD5RGDPK7
displayed a much higher infectivity of colon tissues and
expanded tropism, it did not show specificity to the tumor
tissues. These AD vectors infected mostly epithelial cells within
the mucosa, while AD5RGDPK7 virus infected, in addition,
cells within the mesothelial layer of the normal colon tissue (Fig.
3). Since the only apparent difference among these vectors is
receptor recognition, the results suggest that both extent of
infection and cell tropism in a given tissue are dependent on
expression of the relevant receptor. As enhancement of infection
by the AD5RGDPK7 virus was observed in both the tumor and
the equivalent normal colon tissues, specific targeting of the
tumor by capsid-modified adenovirus would require additional
modifications, such as a promoter that is specific for the tumor
cell over normal cells (Haviv and Curiel, 2003). Targeted vectors
are especially critical when the clinical indication requires
intravenous injection of vectors. In the context of colorectal
tumors, since direct intratumor injection is feasible, lack of tissue
selectivity by theAD5RGDPK7 vector may not hamper the local
treatment.
Heparan sulfate surface molecules are abundantly expressed
on most cell types in the body (Blackhall et al., 2001) and are
used by several viruses as attachment molecule, or an entry
receptor (Dechecchi et al., 2001; Spear, 2004; Tyagi et al.,
2001). The possibility to divert adenovirus from the CAR
receptor, that is often limited on the cell surface, or expressed
predominantly on the basolateral side of epithelial cells
(Bruning and Runnebaum, 2003; Cohen et al., 2001; Hemminki
et al., 2003; Kanerva et al., 2002; Li et al., 1999; Pickles et al.,
2000; Seidman et al., 2001) to the heparan sulfate receptor, as
shown here, is of potential, in several clinical applications. Yet,
heparin, at high concentrations, only partially inhibits infection
of the colon tissue by AD5RGDPK7 virus (Fig. 6). This result
suggests that the capsid-modified AD5RGDPK7 may use
additional receptors in the colon tissue that are distinct of
heparan sulfate molecules. The nature of these additional
receptors is not clear at this point.
Accessibility of permissive cells within a solid tissue to the
infecting viral vector, is an important determinant in the
effectiveness of gene therapy treatments (Brill-Almon et al.,
2005). In the present work, we tested restrictions imposed on
infection by extracellular matrix components. Limited digestion
by collagenase enzyme, while maintaining the basic structure of
the tissue, had a profound enhanced effect on virus infectivity.
This observation is in line with a previous study that
investigated the effect of collagenase injected in vivo directly
to the tissue in mouse (Kuriyama et al., 2001). The organ culture
system presented here may now be applied to further study
interactions of a virus within a solid three dimensional tissue, as
well as the role of extracellular matrix molecules in viruspenetration to a tissue. Eventually, in the context of intratumor
direct application of the vector, as discussed above for colo-
rectal carcinoma, it may be feasible to mix the vector with
extracellular degrading enzymes for enhanced viral infection of
the tumor.
In conclusion, we describe here organ culture systems
derived from tumor and the equivalent normal tissue and
applied it to the study of AD vector tropism. We demon-
strated that receptor utilization as well as extracellular
components within the solid tissue determines both extent
of infection and viral tropism. These preclinical data may now
facilitate new gene therapy approaches for the treatment of
colon carcinoma.
We believe that the significance of this system extends
beyond colon carcinoma and the adenoviral vectors used in the
study, as it should facilitate a more educated selection of viral
vectors, and infection conditions to increase the efficacy and
selectivity of gene transfer technology for solid tissues in
general.
Materials and methods
Cells
CT26 (Balb/C mouse colon carcinoma line) is a gift from
Prof. Y. Keisari, Tel Aviv University. LS174T (human colon
goblet cell line) is a gift from Dr. B. Schwartz (Faculty of
Agriculture, The Hebrew University). 293T (human kidney cell
line), NIH3T3 cells (a mouse fibroblast line). Cell lines were
maintained in DMEM, 10% FCS, 1% MEM Vitamins Solution
(Biological industries, Beit Haemek, Is.), penicillin (100 U/ml)
and streptomycin sulfate (100 μg/ml), at 37 °C in 5% CO2.
Tissues
Human tissues were obtained within 2 h of the surgery
(under approval # 20-01/08/03 of the Hadassah Hospital IRB
committee). For preparation of organ cultures from mice
orthotopic colon tumors, Balb/C mice were anesthetized with
a ketamine–xylazine and injected through the rectum into the
colon mucosa and submucosa with colon carcinoma cells CT26
(2×106 cells/50 μl PBS). Three weeks later. orthotopic tumors
were developed in the colon. Mice were sacrificed and the colon
and adjacent tumor were harvested and prepared for ex vivo
organ culture as described below.
Adenoviruses
AD5, AD5RGD and AD5RGDPK7 are E1-deleted,
replication-defective AD viruses encoding luciferase and
GFP reporter genes in the E1 locale, driven by an individual
and separate identical constitutively active CMV promoter
(Wu et al., 2002).
AD viruses were propagated, purified and concentrated as
described before (Alian et al., 2000). 293T cells were infected
with AD at 0.1 multiplicity of infection (MOI). Two days after
infection, when a robust cytopathic effect was detected, cells
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extract was clarified by centrifugation at 6000×g for 10 min.
Virus was purified by sedimentation through a 10% sucrose
cushion for 2 h at 100,000×g. The virus pellet was resuspended
in phosphate-buffered saline (PBS) and kept at −70 °C.
Virus infectious units (IU) was determined using the GFP
reporter, by end point dilution on both human 293T and mouse
NIH-3T3 cell lines.
SHEM medium
The organ culture medium was “supplemented hormonal
epithelial medium” (SHEM) (Bourcier et al., 2000), consisting
of a 1:1 mixture Dulbecco's modified Eagle's medium
(DMEM) and Ham's F12 with 5% fetal calf serum (FCS),
10 mM HEPES, 0.5% DMSO, 0.5 μg/ml hydrocortison, 1%
MEM vitamins solution (Biological industries, Beit Haemek,
Is.), 5 μg/ml insulin, 5 μg/ml transferin, 5 ng/ml Selenium,
2 ng/ml Epidermal Growth Factor, 100 IU/ml penicillin,
100 μg/ml streptomycin, 15 μg/ml gentamicin and 15 μg/ml
Ciproxin.
Organ cultures
Normal and tumor tissues of human and mouse origin were
washed 5 times in SHEM medium, and cut by a microtome
(Tissue Sectioner, TC-2, Sorvall Corp.) to thin slices (500 μm
thickness) and were incubated in SHEM medium at 37 °C, 5%
CO2 (5 slices/well in a 48 wells plate) (Hasson et al., 2005).
Infection of organ cultures
Organ culture tissues were infected with identical doses of
the different adenovirus (as determined on both 293 and
NIH3T3 cells) in 300 μl SHEM medium/well. Two hours post
infection, 5% FCS was added to the medium and tissues
incubated for further 22 h at 37 °C, 5% CO2.
Luciferase enzyme assay
Organ culture tissues infected for 24 h were extracted with
lysis buffer (100 μl PBS, 0.1% Triton-X100), freeze-thawed
twice, sonicated and the extract was clarified by centrifugation
(3000×g for 10 min). Supernatant extracts (20 μl) were mixed
with 50 μl of luciferase assay reagent (Promega Corp.) and the
level of reporter luciferase activity was examined in a
luminometer (Mithras-LB940, Berthold Corp.) (Honigman et
al., 2001; Wu et al., 2002). Enzyme specific activity is
determined by correction to protein content of the extracts,
tested in Bradford assay (Bradford, 1976).
MTT cell viability assay
The assay is based upon the activity of mitochondrial
dehydrogenase to convert MTT substrate (3-[4,5-dimethylthia-
zol-2-yl-2,5-diphenyltetrazolium bromide]) (Sigma Corp.) into
a blue formazan product. Tissue slices were incubated with theMTT substrate for 60 min at 37 °C, followed by the addition of
100% ethanol to dissolve the product colored crystals. Samples
were read using an ELISA plate reader (Organon Teknika,
Netherlands) at a wavelength of 540 nm in reference to 650 nm
(Zhang et al., 2000). Cell viability is determined after correction
to protein content of the extract.
Histology analysis
For routine histological analysis, formalin-fixed paraffin-
embedded tissues were cut (5 μm sections), deparaffinized in
xylene and dehydrated. Sections were stained with hematoxylin
and eosin. For immunohistochemical detection of luciferase
antigen, paraffin-embedded sections were pretreated in 0.01 M
citrate buffer and heated in a microwave oven twice for 5 min.
Samples were incubated with rabbit polyclonal antibodies
against luciferase (1:100 dilution; Cortex Biochem, CA),
washed and incubated with Biotin-conjugated anti-rabbit goat
antibody (1:100 dilution; Jackson Immunoresearch, PA). The
samples were then labeled with peroxidase-conjugated strepta-
vidin. Luciferase antigen was detected using 3-amino-9-ethyl
carbazole substrate and counter-stained with hematoxylin (Iris
et al., 2003).
For immunohistochemical detection of GFP antigen, paraf-
fin-embedded sections were pretreated as described above and
incubated with chicken polyclonal antibodies against GFP
(1:1000 dilution, a kind gift from Y. Dor, The Hebrew Uni-
versity, Jerusalem). The samples were washed and incubated
with Biotin-conjugated donkey antibody against chicken serum
(1:400 dilution, Jackson Corp. PA). Samples were labeled with
peroxidase-conjugated Streptavidin as described above for
luciferase immunostaining.
Tissue DNA content
Cell number in the solid tissue was determined by DNA
content assay (Downs and Wilfinger, 1983). Normalizing the
assay was done by taking the same number of tissue slices for
the DNA content and for protein determination. Tissues slices
were homogenized in AT extraction solution (1N NH4OH,
0.2% Triton X-100), incubated in 37 °C for 10 min and diluted
in assay buffer (100 mM NaCl, 10 mM EDTA, 10 mM Tris, pH
7.0). After centrifugation, aliquots (50 μl) from the sample were
added to Hoechst 33258 reagent (100 ng/ml). Fluorescence was
measured on Perkin-Elmer Model 650-10S fluorescence
spectrometer with the excitation and emission wavelength set
at 350 and 455 nm, respectively. Standard curve was prepared
using salmon sperm DNA.
Number of cells in a tissues was determined by the formula:
7 pg of DNA per cell (Downs and Wilfinger, 1983).
Statistics
All data are presented as means±SD. Statistical differences
among groups were assessed with a two-tailed Student's
t test. p<0.05 was considered significant and marked by an
asterisk (*).
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